Clinical Trial Update: Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing short-course radiotherapy with CAPOX plus a PD-1 antibody versus long-course chemoradiotherapy with CAPOX in patients with early low-lyi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• PD-1 antibody (PD-1 inhibitor)

Snippet

Sponsor: Fudan University | Conditions: Early Low Rectal Cancer | Phase 2 | Status: RECRUITING